11/7/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE CONSEIL DE IEUROPE | 2 | NOS | 156.56 | FRANCE | BANGALORE ACC |
8/29/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE CONSEIL DE IEUROPE | 5 | NOS | 405.11 | FRANCE | BANGALORE ACC |
6/20/2023 | 38229090 | EP-ICRS1552-ABACAVIR SUIFATE FOR SYSTEM SUITABILITY RS-10MG-PHARMACEUTICAL REFERENCE STANDARD | COUNCIL OF EUROPE CONSEIL DE | 3 | NOS | 234.83 | France | BANGALORE AIR |
5/16/2023 | 38229090 | EP-ICRS1552-ABACAVIR SULFATE FOR SYSTEM SUITABILITY RS-(10MG)-(PHARMACEUTICAL REFERENCE STANDARD) | COUNCIL OF EUROPE CONSEIL DE IEUROPE | 1 | NOS | 81.21 | FRANCE | BANGALORE ACC |
4/17/2023 | 38229090 | (FOC)-USP-1000408-ABACAVIR SULFATE-(200MG)-(PHARMACEUTICAL REFERENCE STANDARD) | THE UNITED STATES PHARMACOPEIAL CONVENTION INC | 1 | NOS | 229.35 | USA | BANGALORE ACC |